Skip to main content
. 2021 Jun 25;10(7):1026. doi: 10.3390/antiox10071026

Table 1.

General characteristics of the subjects.

Control Group
(n = 34)
Treatment Group
(n = 33)
Total
(n = 67)
p-Value
Age (years) 63.5 ± 3.7 64.8 ± 3.7 64.1 ± 3.7 0.177
Sex
Male (n, %) 5 (14.7) 5 (15.2) 10 (14.9) 0.959
Female (n, %) 29 (85.3) 28 (84.8) 57 (85.1)
Height (cm) 157.0 ± 5.2 157.7 ± 6.4 157.3 ± 5.8 0.639
Weight (kg) 58.2 ± 9.3 61.2 ± 8.0 59.7 ± 8.8 0.158
BMI (kg/m2) 23.5 ± 2.9 24.6 ± 2.5 24.0 ± 2.8 0.121
SBP (mmHg) 125.9 ± 12.2 124.5 ± 14.0 120.9 ± 13.5 0.664
DBP (mmHg) 75.5 ± 7.8 77.2 ± 9.7 74.3 ± 10.3 0.665
Pulse (times/min) 73.5 ± 9.3 76.2 ± 9.7 72.7 ± 10.1 0.263
Alcohol (n, %) 8 (23.5%) 5 (15.2%) 13 (19.4%) 0.493
Smoking (n, %) 0 (0.0%) 1 (3.0%) 1 (1.5%) 0.306

Values are presented as the mean ± standard deviation. p-Values were determined by an independent t-test or chi-square test.